FDA Guidance on Combination Hypertension Drugs Offers Alternatives to Larger Trials

Drug Industry Daily
A A
Drug sponsors can prove the effectiveness of combination drugs for treatment of hypertension with trials that test the highest approved dosage rather than trials with multiple doses, the FDA said in new draft guidance for developing such products.

To View This Article:

Login

Subscribe To Drug Industry Daily